APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Microbiology

Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.

Selected research

Market Outlook & Growth Opportunities

Global Molecular Microbiology Market Outlook and Growth Opportunities 2026

1 January 2026197 pages

Choose your research edition.

Industry ResearchMolecular Microbiology Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Microbiology Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Molecular Microbiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Microbiology Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Microbiology Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.

Global Molecular Microbiology key players include Roche, Qiagen, Illumina, Abbott, BioMerieux, etc. Global top five manufacturers hold a share about 65%. North America is the largest market, with a share about 50%, followed by Europe, with a share about 30 percent. In terms of product, Quantitative PCR Detection Diagnostic Kits is the largest segment, with a share about 45%. And in terms of application, the largest application is Human, followed by Veterinary.

This report provides an overview of the global Molecular Microbiology market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Molecular Microbiology and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Microbiology sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Molecular Microbiology market size, projected growth trends, production technologies, key applications, and end-use industries.

Molecular Microbiology Segment by Company

Roche

Qiagen

Illumina

Abbott

Hologic

BioMerieux

Danaher (Cepheid)

Myriad Genetics

DAAN Gene

Agilent

Genomic Health

BD

Foundation Medicine

Molecular Microbiology Segment by Type

Quantitative PCR Detection Diagnostic Kits

Pathogenic Microorganisms Diagnostic Kits

Other

Molecular Microbiology Segment by Application

Human

Veterinary

Molecular Microbiology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Molecular Microbiology status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Molecular Microbiology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Molecular Microbiology significant trends, drivers, influence factors in global and regions.

6. To analyze Molecular Microbiology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Microbiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Microbiology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Microbiology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Molecular Microbiology market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Microbiology industry.

Chapter 3: Detailed analysis of Molecular Microbiology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Molecular Microbiology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Molecular Microbiology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Molecular Microbiology Industry Trends Table 2. Molecular Microbiology Industry Drivers Table 3. Molecular Microbiology Industry Opportunities and Challenges Table 4. Molecular Microbiology Industry Restraints Table 5. Global Molecular Microbiology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Molecular Microbiology Revenue Share by Company (2021-2026) Table 7. Global Molecular Microbiology Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Molecular Microbiology Sales Volume Share by Company (2021-2026) Table 9. Global Molecular Microbiology Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Molecular Microbiology Company Ranking, (2024-2026) & (USD Million) Table 11. Global Molecular Microbiology Key Company Manufacturing Base & Headquarters Table 12. Global Molecular Microbiology Company, Product Type & Application Table 13. Global Molecular Microbiology Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Molecular Microbiology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Quantitative PCR Detection Diagnostic Kits Table 18. Significant Companies of Pathogenic Microorganisms Diagnostic Kits Table 19. Significant Companies of Other Table 20. Global Molecular Microbiology Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Molecular Microbiology Sales Volume by Type (2021-2026) & (M Units) Table 22. Global Molecular Microbiology Sales Volume by Type (2027-2032) & (M Units) Table 23. Global Molecular Microbiology Sales Volume Share by Type (2021-2026) Table 24. Global Molecular Microbiology Sales Volume Share by Type (2027-2032) Table 25. Global Molecular Microbiology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Molecular Microbiology Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Molecular Microbiology Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Molecular Microbiology Sales Value Share by Type (2021-2026) Table 29. Global Molecular Microbiology Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Human Table 31. Significant Companies of Veterinary Table 32. Global Molecular Microbiology Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Molecular Microbiology Sales Volume by Application (2021-2026) & (M Units) Table 34. Global Molecular Microbiology Sales Volume by Application (2027-2032) & (M Units) Table 35. Global Molecular Microbiology Sales Volume Share by Application (2021-2026) Table 36. Global Molecular Microbiology Sales Volume Share by Application (2027-2032) Table 37. Global Molecular Microbiology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Molecular Microbiology Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Molecular Microbiology Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Molecular Microbiology Sales Value Share by Application (2021-2026) Table 41. Global Molecular Microbiology Sales Value Share by Application (2027-2032) Table 42. Global Molecular Microbiology Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Molecular Microbiology Sales by Region (2021-2026) & (M Units) Table 44. Global Molecular Microbiology Sales Market Share by Region (2021-2026) Table 45. Global Molecular Microbiology Sales by Region (2027-2032) & (M Units) Table 46. Global Molecular Microbiology Sales Market Share by Region (2027-2032) Table 47. Global Molecular Microbiology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Molecular Microbiology Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Molecular Microbiology Sales Value Share by Region (2021-2026) Table 50. Global Molecular Microbiology Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Molecular Microbiology Sales Value Share by Region (2027-2032) Table 52. Global Molecular Microbiology Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Molecular Microbiology Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Molecular Microbiology Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Global Molecular Microbiology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Molecular Microbiology Sales by Country (2021-2026) & (M Units) Table 57. Global Molecular Microbiology Sales Market Share by Country (2021-2026) Table 58. Global Molecular Microbiology Sales by Country (2027-2032) & (M Units) Table 59. Global Molecular Microbiology Sales Market Share by Country (2027-2032) Table 60. Global Molecular Microbiology Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Molecular Microbiology Sales Value Market Share by Country (2021-2026) Table 62. Global Molecular Microbiology Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Molecular Microbiology Sales Value Market Share by Country (2027-2032) Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Roche Molecular Microbiology Product Portfolio Table 68. Roche Recent Development Table 69. Qiagen Company Information Table 70. Qiagen Business Overview Table 71. Qiagen Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Qiagen Molecular Microbiology Product Portfolio Table 73. Qiagen Recent Development Table 74. Illumina Company Information Table 75. Illumina Business Overview Table 76. Illumina Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Illumina Molecular Microbiology Product Portfolio Table 78. Illumina Recent Development Table 79. Abbott Company Information Table 80. Abbott Business Overview Table 81. Abbott Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Abbott Molecular Microbiology Product Portfolio Table 83. Abbott Recent Development Table 84. Hologic Company Information Table 85. Hologic Business Overview Table 86. Hologic Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Hologic Molecular Microbiology Product Portfolio Table 88. Hologic Recent Development Table 89. BioMerieux Company Information Table 90. BioMerieux Business Overview Table 91. BioMerieux Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. BioMerieux Molecular Microbiology Product Portfolio Table 93. BioMerieux Recent Development Table 94. Danaher (Cepheid) Company Information Table 95. Danaher (Cepheid) Business Overview Table 96. Danaher (Cepheid) Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Danaher (Cepheid) Molecular Microbiology Product Portfolio Table 98. Danaher (Cepheid) Recent Development Table 99. Myriad Genetics Company Information Table 100. Myriad Genetics Business Overview Table 101. Myriad Genetics Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Myriad Genetics Molecular Microbiology Product Portfolio Table 103. Myriad Genetics Recent Development Table 104. DAAN Gene Company Information Table 105. DAAN Gene Business Overview Table 106. DAAN Gene Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. DAAN Gene Molecular Microbiology Product Portfolio Table 108. DAAN Gene Recent Development Table 109. Agilent Company Information Table 110. Agilent Business Overview Table 111. Agilent Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Agilent Molecular Microbiology Product Portfolio Table 113. Agilent Recent Development Table 114. Genomic Health Company Information Table 115. Genomic Health Business Overview Table 116. Genomic Health Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Genomic Health Molecular Microbiology Product Portfolio Table 118. Genomic Health Recent Development Table 119. BD Company Information Table 120. BD Business Overview Table 121. BD Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. BD Molecular Microbiology Product Portfolio Table 123. BD Recent Development Table 124. Foundation Medicine Company Information Table 125. Foundation Medicine Business Overview Table 126. Foundation Medicine Molecular Microbiology Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. Foundation Medicine Molecular Microbiology Product Portfolio Table 128. Foundation Medicine Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Molecular Microbiology Distributors List Table 132. Molecular Microbiology Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Molecular Microbiology Product Image Figure 2. Global Molecular Microbiology Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Microbiology Sales Value (2021-2032) & (US$ Million) Figure 4. Global Molecular Microbiology Sales (2021-2032) & (M Units) Figure 5. Global Molecular Microbiology Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Molecular Microbiology Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Quantitative PCR Detection Diagnostic Kits Image Figure 10. Pathogenic Microorganisms Diagnostic Kits Image Figure 11. Other Image Figure 12. Global Molecular Microbiology Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Molecular Microbiology Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Molecular Microbiology Sales Volume Share by Type (2021-2032) Figure 15. Global Molecular Microbiology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Molecular Microbiology Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Molecular Microbiology Sales Value Share by Type (2021-2032) Figure 18. Human Image Figure 19. Veterinary Image Figure 20. Global Molecular Microbiology Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Molecular Microbiology Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Molecular Microbiology Sales Volume Share by Application (2021-2032) Figure 23. Global Molecular Microbiology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Molecular Microbiology Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Molecular Microbiology Sales Value Share by Application (2021-2032) Figure 26. Global Molecular Microbiology Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 27. Global Molecular Microbiology Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Molecular Microbiology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Molecular Microbiology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Molecular Microbiology Sales Value (2021-2032) & (US$ Million) Figure 31. North America Molecular Microbiology Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Molecular Microbiology Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Molecular Microbiology Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Molecular Microbiology Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Molecular Microbiology Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Molecular Microbiology Sales Value (2021-2032) & (US$ Million) Figure 37. South America Molecular Microbiology Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Molecular Microbiology Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Molecular Microbiology Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Molecular Microbiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Molecular Microbiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Molecular Microbiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Molecular Microbiology Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Molecular Microbiology Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Quantitative PCR Detection Diagnostic Kits
  • Pathogenic Microorganisms Diagnostic Kits
  • Other
Applications
  • Human
  • Veterinary
Companies covered
  • Roche
  • Qiagen
  • Illumina
  • Abbott
  • Hologic
  • BioMerieux
  • Danaher (Cepheid)
  • Myriad Genetics
  • DAAN Gene
  • Agilent
  • Genomic Health
  • BD
  • Foundation Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Molecular Microbiology Sales Value (2021-2032)
  4. 1.2.2 Global Molecular Microbiology Sales Volume (2021-2032)
  5. 1.2.3 Global Molecular Microbiology Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Molecular Microbiology Market Dynamics
  1. 2.1 Molecular Microbiology Industry Trends
  2. 2.2 Molecular Microbiology Industry Drivers
  3. 2.3 Molecular Microbiology Industry Opportunities and Challenges
  4. 2.4 Molecular Microbiology Industry Restraints
3 Molecular Microbiology Market by Company
  1. 3.1 Global Molecular Microbiology Company Revenue Ranking in 2025
  2. 3.2 Global Molecular Microbiology Revenue by Company (2021-2026)
  3. 3.3 Global Molecular Microbiology Sales Volume by Company (2021-2026)
  4. 3.4 Global Molecular Microbiology Average Price by Company (2021-2026)
  5. 3.5 Global Molecular Microbiology Company Ranking (2024-2026)
  6. 3.6 Global Molecular Microbiology Company Manufacturing Base and Headquarters
  7. 3.7 Global Molecular Microbiology Company Product Type and Application
  8. 3.8 Global Molecular Microbiology Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Molecular Microbiology Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Molecular Microbiology Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Molecular Microbiology Market by Type
  1. 4.1 Molecular Microbiology Type Introduction
  2. 4.1.1 Quantitative PCR Detection Diagnostic Kits
  3. 4.1.2 Pathogenic Microorganisms Diagnostic Kits
  4. 4.1.3 Other
  5. 4.2 Global Molecular Microbiology Sales Volume by Type
  6. 4.2.1 Global Molecular Microbiology Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Molecular Microbiology Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Molecular Microbiology Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Molecular Microbiology Sales Value by Type
  10. 4.3.1 Global Molecular Microbiology Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Molecular Microbiology Sales Value by Type (2021-2032)
  12. 4.3.3 Global Molecular Microbiology Sales Value Share by Type (2021-2032)
5 Molecular Microbiology Market by Application
  1. 5.1 Molecular Microbiology Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Molecular Microbiology Sales Volume by Application
  5. 5.2.1 Global Molecular Microbiology Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Molecular Microbiology Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Molecular Microbiology Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Molecular Microbiology Sales Value by Application
  9. 5.3.1 Global Molecular Microbiology Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Molecular Microbiology Sales Value by Application (2021-2032)
  11. 5.3.3 Global Molecular Microbiology Sales Value Share by Application (2021-2032)
6 Molecular Microbiology Regional Sales and Value Analysis
  1. 6.1 Global Molecular Microbiology Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Microbiology Sales by Region (2021-2032)
  3. 6.2.1 Global Molecular Microbiology Sales by Region: 2021-2026
  4. 6.2.2 Global Molecular Microbiology Sales by Region (2027-2032)
  5. 6.3 Global Molecular Microbiology Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Molecular Microbiology Sales Value by Region (2021-2032)
  7. 6.4.1 Global Molecular Microbiology Sales Value by Region: 2021-2026
  8. 6.4.2 Global Molecular Microbiology Sales Value by Region (2027-2032)
  9. 6.5 Global Molecular Microbiology Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Molecular Microbiology Sales Value (2021-2032)
  12. 6.6.2 North America Molecular Microbiology Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Molecular Microbiology Sales Value (2021-2032)
  15. 6.7.2 Europe Molecular Microbiology Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Molecular Microbiology Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Molecular Microbiology Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Molecular Microbiology Sales Value (2021-2032)
  21. 6.9.2 South America Molecular Microbiology Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Molecular Microbiology Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Molecular Microbiology Sales Value Share by Country, 2025 VS 2032
7 Molecular Microbiology Country-level Sales and Value Analysis
  1. 7.1 Global Molecular Microbiology Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Molecular Microbiology Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Molecular Microbiology Sales by Country (2021-2032)
  4. 7.3.1 Global Molecular Microbiology Sales by Country (2021-2026)
  5. 7.3.2 Global Molecular Microbiology Sales by Country (2027-2032)
  6. 7.4 Global Molecular Microbiology Sales Value by Country (2021-2032)
  7. 7.4.1 Global Molecular Microbiology Sales Value by Country (2021-2026)
  8. 7.4.2 Global Molecular Microbiology Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Molecular Microbiology Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Molecular Microbiology Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Molecular Microbiology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Molecular Microbiology Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Molecular Microbiology Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Molecular Microbiology Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Molecular Microbiology Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Molecular Microbiology Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Molecular Microbiology Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Molecular Microbiology Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Molecular Microbiology Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Molecular Microbiology Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Molecular Microbiology Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Molecular Microbiology Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Molecular Microbiology Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Molecular Microbiology Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Molecular Microbiology Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Molecular Microbiology Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Molecular Microbiology Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Molecular Microbiology Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Molecular Microbiology Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Molecular Microbiology Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Molecular Microbiology Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Molecular Microbiology Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Molecular Microbiology Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Molecular Microbiology Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Molecular Microbiology Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Molecular Microbiology Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Molecular Microbiology Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Molecular Microbiology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Molecular Microbiology Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Qiagen
  8. 8.2.1 Qiagen Company Information
  9. 8.2.2 Qiagen Business Overview
  10. 8.2.3 Qiagen Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Qiagen Molecular Microbiology Product Portfolio
  12. 8.2.5 Qiagen Recent Developments
  13. 8.3 Illumina
  14. 8.3.1 Illumina Company Information
  15. 8.3.2 Illumina Business Overview
  16. 8.3.3 Illumina Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Illumina Molecular Microbiology Product Portfolio
  18. 8.3.5 Illumina Recent Developments
  19. 8.4 Abbott
  20. 8.4.1 Abbott Company Information
  21. 8.4.2 Abbott Business Overview
  22. 8.4.3 Abbott Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Molecular Microbiology Product Portfolio
  24. 8.4.5 Abbott Recent Developments
  25. 8.5 Hologic
  26. 8.5.1 Hologic Company Information
  27. 8.5.2 Hologic Business Overview
  28. 8.5.3 Hologic Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hologic Molecular Microbiology Product Portfolio
  30. 8.5.5 Hologic Recent Developments
  31. 8.6 BioMerieux
  32. 8.6.1 BioMerieux Company Information
  33. 8.6.2 BioMerieux Business Overview
  34. 8.6.3 BioMerieux Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BioMerieux Molecular Microbiology Product Portfolio
  36. 8.6.5 BioMerieux Recent Developments
  37. 8.7 Danaher (Cepheid)
  38. 8.7.1 Danaher (Cepheid) Company Information
  39. 8.7.2 Danaher (Cepheid) Business Overview
  40. 8.7.3 Danaher (Cepheid) Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Danaher (Cepheid) Molecular Microbiology Product Portfolio
  42. 8.7.5 Danaher (Cepheid) Recent Developments
  43. 8.8 Myriad Genetics
  44. 8.8.1 Myriad Genetics Company Information
  45. 8.8.2 Myriad Genetics Business Overview
  46. 8.8.3 Myriad Genetics Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Myriad Genetics Molecular Microbiology Product Portfolio
  48. 8.8.5 Myriad Genetics Recent Developments
  49. 8.9 DAAN Gene
  50. 8.9.1 DAAN Gene Company Information
  51. 8.9.2 DAAN Gene Business Overview
  52. 8.9.3 DAAN Gene Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 DAAN Gene Molecular Microbiology Product Portfolio
  54. 8.9.5 DAAN Gene Recent Developments
  55. 8.10 Agilent
  56. 8.10.1 Agilent Company Information
  57. 8.10.2 Agilent Business Overview
  58. 8.10.3 Agilent Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Agilent Molecular Microbiology Product Portfolio
  60. 8.10.5 Agilent Recent Developments
  61. 8.11 Genomic Health
  62. 8.11.1 Genomic Health Company Information
  63. 8.11.2 Genomic Health Business Overview
  64. 8.11.3 Genomic Health Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Genomic Health Molecular Microbiology Product Portfolio
  66. 8.11.5 Genomic Health Recent Developments
  67. 8.12 BD
  68. 8.12.1 BD Company Information
  69. 8.12.2 BD Business Overview
  70. 8.12.3 BD Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BD Molecular Microbiology Product Portfolio
  72. 8.12.5 BD Recent Developments
  73. 8.13 Foundation Medicine
  74. 8.13.1 Foundation Medicine Company Information
  75. 8.13.2 Foundation Medicine Business Overview
  76. 8.13.3 Foundation Medicine Molecular Microbiology Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Foundation Medicine Molecular Microbiology Product Portfolio
  78. 8.13.5 Foundation Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Molecular Microbiology Value Chain Analysis
  2. 9.1.1 Molecular Microbiology Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Molecular Microbiology Sales Mode & Process
  6. 9.2 Molecular Microbiology Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Molecular Microbiology Distributors
  9. 9.2.3 Molecular Microbiology Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst